Cancer Research Annual Meeting 2010 Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ganss, R.
Right arrow Articles by Hämmerling, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ganss, R.
Right arrow Articles by Hämmerling, G. J.
[Cancer Research 62, 1462-1470, March 1, 2002]
© 2002 American Association for Cancer Research

Immunology

Combination of T-Cell Therapy and Trigger of Inflammation Induces Remodeling of the Vasculature and Tumor Eradication1

Ruth Ganss2, Eduard Ryschich, Ernst Klar, Bernd Arnold and Günter J. Hämmerling

Department of Molecular Immunology, German Cancer Research Center [R. G., B. A., G. J. H.], and Department of Surgery, University of Heidelberg [E. R., E. K.], 69120 Heidelberg, Germany

In a transgenic mouse model of multistep carcinogenesis, highly angiogenic insulinomas contain an irregular vascular network and develop an intrinsic resistance to leukocyte infiltration and effector function. Even persistently high levels of activated tumor-specific T lymphocytes fail to eradicate the tumors. In contrast, we show that irradiation before adoptive transfer results in complete macroscopic tumor regression. Thus, effective tumor therapy requires a proinflammatory microenvironment that permits T cells to extravasate and to destroy the tumor. Early after initiation of the irradiation/adoptive transfer therapy, the capillary network reacquires an almost normal appearance, a likely consequence of strong induction of the chemokines monokine induced by IFN-{gamma} (Mig) and IFN-inducible protein 10 (IP10). This remodeling of the vasculature in a proinflammatory environment may directly affect lymphocyte extravasation and effector function. Therefore, irradiation/adoptive transfer therapy combines antigen-driven tumor cell eradication with antiangiogenic effects on tumor endothelium, a powerful synergy that has not been previously appreciated.




This article has been cited by other articles:


Home page
 BloodHome page
K. Hochweller, T. Miloud, J. Striegler, S. Naik, G. J. Hammerling, and N. Garbi
Homeostasis of dendritic cells in lymphoid organs is controlled by regulation of their precursors via a feedback loop
Blood, November 12, 2009; 114(20): 4411 - 4421.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Hamzah, J. G. Altin, T. Herringson, C. R. Parish, G. J. Hammerling, H. O'Donoghue, and R. Ganss
Targeted Liposomal Delivery of TLR9 Ligands Activates Spontaneous Antitumor Immunity in an Autochthonous Cancer Model
J. Immunol., July 15, 2009; 183(2): 1091 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Manzur, J. Hamzah, and R. Ganss
Modulation of G Protein Signaling Normalizes Tumor Vessels
Cancer Res., January 15, 2009; 69(2): 396 - 399.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. M. Tatum, L. M. Mylin, S. J. Bender, M. A. Fischer, B. A. Vigliotti, M. J. Tevethia, S. S. Tevethia, and T. D. Schell
CD8+ T Cells Targeting a Single Immunodominant Epitope are Sufficient for Elimination of Established SV40 T Antigen-Induced Brain Tumors
J. Immunol., September 15, 2008; 181(6): 4406 - 4417.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. A. Quezada, K. S. Peggs, T. R. Simpson, Y. Shen, D. R. Littman, and J. P. Allison
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
J. Exp. Med., September 1, 2008; 205(9): 2125 - 2138.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Matsumura, B. Wang, N. Kawashima, S. Braunstein, M. Badura, T. O. Cameron, J. S. Babb, R. J. Schneider, S. C. Formenti, M. L. Dustin, et al.
Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
J. Immunol., September 1, 2008; 181(5): 3099 - 3107.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Iuchi, S. Teitz-Tennenbaum, J. Huang, B. G. Redman, S. D. Hughes, M. Li, G. Jiang, A. E. Chang, and Q. Li
Interleukin-21 Augments the Efficacy of T-Cell Therapy by Eliciting Concurrent Cellular and Humoral Responses
Cancer Res., June 1, 2008; 68(11): 4431 - 4441.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Jorritsma, A. D. Bins, T. N.M. Schumacher, and J. B.A.G. Haanen
Skewing the T-Cell Repertoire by Combined DNA Vaccination, Host Conditioning, and Adoptive Transfer
Cancer Res., April 1, 2008; 68(7): 2455 - 2462.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. B. J. Wong, R. Bos, and L. A. Sherman
Tumor-Specific CD4+ T Cells Render the Tumor Environment Permissive for Infiltration by Low-Avidity CD8+ T Cells
J. Immunol., March 1, 2008; 180(5): 3122 - 3131.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Otahal, B. B. Knowles, S. S. Tevethia, and T. D. Schell
Anti-CD40 Conditioning Enhances the TCD8 Response to a Highly Tolerogenic Epitope and Subsequent Immunotherapy of Simian Virus 40 T Antigen-Induced Pancreatic Tumors
J. Immunol., November 15, 2007; 179(10): 6686 - 6695.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. A. Manning, J. G.M. Ullman, J. M. Leatherman, J. M. Asquith, T. R. Hansen, T. D. Armstrong, D. J. Hicklin, E. M. Jaffee, and L. A. Emens
A Vascular Endothelial Growth Factor Receptor-2 Inhibitor Enhances Antitumor Immunity through an Immune-Based Mechanism
Clin. Cancer Res., July 1, 2007; 13(13): 3951 - 3959.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Perez-Diez, N. T. Joncker, K. Choi, W. F. N. Chan, C. C. Anderson, O. Lantz, and P. Matzinger
CD4 cells can be more efficient at tumor rejection than CD8 cells
Blood, June 15, 2007; 109(12): 5346 - 5354.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
B. Zhang, N. A. Bowerman, J. K. Salama, H. Schmidt, M. T. Spiotto, A. Schietinger, P. Yu, Y.-X. Fu, R. R. Weichselbaum, D. A. Rowley, et al.
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells
J. Exp. Med., January 22, 2007; 204(1): 49 - 55.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
D. Nelson and R. Ganss
Tumor growth or regression: powered by inflammation
J. Leukoc. Biol., October 1, 2006; 80(4): 685 - 690.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Otahal, T. D. Schell, S. C. Hutchinson, B. B. Knowles, and S. S. Tevethia
Early Immunization Induces Persistent Tumor-Infiltrating CD8+ T Cells against an Immunodominant Epitope and Promotes Lifelong Control of Pancreatic Tumor Progression in SV40 Tumor Antigen Transgenic Mice.
J. Immunol., September 1, 2006; 177(5): 3089 - 3099.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
E. A. Reits, J. W. Hodge, C. A. Herberts, T. A. Groothuis, M. Chakraborty, E. K.Wansley, K. Camphausen, R. M. Luiten, A. H. de Ru, J. Neijssen, et al.
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
J. Exp. Med., May 15, 2006; 203(5): 1259 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. I. Garbe, B. Vermeer, J. Gamrekelashvili, R. v. Wasielewski, F. R. Greten, A. M. Westendorf, J. Buer, R. M. Schmid, M. P. Manns, F. Korangy, et al.
Genetically Induced Pancreatic Adenocarcinoma Is Highly Immunogenic and Causes Spontaneous Tumor-Specific Immune Responses
Cancer Res., January 1, 2006; 66(1): 508 - 516.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
A Limmer, R Ganss, N Garbi, B Arnold, and G J Hammerling
Stimulation of autoimmunity by toll-like receptor ligands
Ann Rheum Dis, November 1, 2005; 64(suppl_4): iv15 - iv17.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
A. A. Lugade, J. P. Moran, S. A. Gerber, R. C. Rose, J. G. Frelinger, and E. M. Lord
Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor
J. Immunol., June 15, 2005; 174(12): 7516 - 7523.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Avogadri, C. Martinoli, L. Petrovska, C. Chiodoni, P. Transidico, V. Bronte, R. Longhi, M. P. Colombo, G. Dougan, and M. Rescigno
Cancer Immunotherapy Based on Killing of Salmonella-Infected Tumor Cells
Cancer Res., May 1, 2005; 65(9): 3920 - 3927.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Berger, G. Bergers, B. Arnold, G. J. Hammerling, and R. Ganss
Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization
Blood, February 1, 2005; 105(3): 1094 - 1101.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Demaria, N. Kawashima, A. M. Yang, M. L. Devitt, J. S. Babb, J. P. Allison, and S. C. Formenti
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
Clin. Cancer Res., January 15, 2005; 11(2): 728 - 734.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. M. Bendle, A. Holler, L.-K. Pang, S. Hsu, M. Krampera, E. Simpson, and H. J. Stauss
Induction of Unresponsiveness Limits Tumor Protection by Adoptively Transferred MDM2-Specific Cytotoxic T Lymphocytes
Cancer Res., November 1, 2004; 64(21): 8052 - 8056.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Chakraborty, S. I. Abrams, C. N. Coleman, K. Camphausen, J. Schlom, and J. W. Hodge
External Beam Radiation of Tumors Alters Phenotype of Tumor Cells to Render Them Susceptible to Vaccine-Mediated T-Cell Killing
Cancer Res., June 15, 2004; 64(12): 4328 - 4337.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Garbi, B. Arnold, S. Gordon, G. J. Hammerling, and R. Ganss
CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction
J. Immunol., May 15, 2004; 172(10): 5861 - 5869.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Chamoto, T. Tsuji, H. Funamoto, A. Kosaka, J. Matsuzaki, T. Sato, H. Abe, K. Fujio, K. Yamamoto, T. Kitamura, et al.
Potentiation of Tumor Eradication by Adoptive Immunotherapy with T-cell Receptor Gene-Transduced T-Helper Type 1 Cells
Cancer Res., January 1, 2004; 64(1): 386 - 390.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Teitz-Tennenbaum, Q. Li, S. Rynkiewicz, F. Ito, M. A. Davis, C. J. Mcginn, and A. E. Chang
Radiotherapy Potentiates the Therapeutic Efficacy of Intratumoral Dendritic Cell Administration
Cancer Res., December 1, 2003; 63(23): 8466 - 8475.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Chakraborty, S. I. Abrams, K. Camphausen, K. Liu, T. Scott, C. N. Coleman, and J. W. Hodge
Irradiation of Tumor Cells Up-Regulates Fas and Enhances CTL Lytic Activity and CTL Adoptive Immunotherapy
J. Immunol., June 15, 2003; 170(12): 6338 - 6347.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Peng, J. Kjaergaard, G. E. Plautz, M. Awad, J. A. Drazba, S. Shu, and P. A. Cohen
Tumor-Induced L-Selectinhigh Suppressor T Cells Mediate Potent Effector T Cell Blockade and Cause Failure of Otherwise Curative Adoptive Immunotherapy
J. Immunol., November 1, 2002; 169(9): 4811 - 4821.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.